Feedback / Questions
AZD8205 - AstraZeneca
AZD8205: Data from P1/2 trial (NCT05123482) for solid tumors in 2025
(AstraZeneca)
-
Feb 28, 2024 -
Q4 & FY2023 Results
P1/2 data
•
Biliary Tract Cancer • Breast Cancer • Endometrial Cancer • Oncology • Ovarian Cancer • Solid Tumor
https://www.astrazeneca.com/content/astraz/investor-relations/full-year-and-q4-2023-results-event.html
Feb 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious